These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3595812)
1. Familial malignant blood disease in the country of Jämtland, Sweden. Eriksson M; Bergström I Eur J Haematol; 1987 Mar; 38(3):241-5. PubMed ID: 3595812 [TBL] [Abstract][Full Text] [Related]
2. Familial occurrence of chronic lymphocytic leukaemia in Norway. Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196 [TBL] [Abstract][Full Text] [Related]
3. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Eriksson M; Hållberg B Cancer Causes Control; 1992 Jan; 3(1):63-7. PubMed ID: 1536915 [TBL] [Abstract][Full Text] [Related]
4. Incidence of hematopoietic malignancies in a well-defined population in France. Carli PM; Milan C; Lorenzini JL; Guy H; Michiels R Oncology; 1986; 43(6):354-7. PubMed ID: 3808567 [TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative and myeloproliferative disease in Tasmania. Lickiss JN; Baikie AG; Panton J Natl Cancer Inst Monogr; 1977 Dec; 47():37-9. PubMed ID: 613244 [TBL] [Abstract][Full Text] [Related]
6. [Familial myeloproliferative syndromes. Study of 6 families and review of literature]. Kaufman S; Brière J; Bernard J Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period]. Jakó J; Szerafin L Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599 [TBL] [Abstract][Full Text] [Related]
8. Retrospective epidemiological study of hemopoietic system neoplasms in Argentina. Quiroga Micheo E; Calcagno EJ; Calabria SI; Besuschio SC; Magnasco JH; Sackmann Muriel F; Maccione E; Barros C; Santoro A; de Soto ZC Medicina (B Aires); 1981; 41(2):187-200. PubMed ID: 7278616 [No Abstract] [Full Text] [Related]
9. [Concurrent lymphoproliferative and myeloproliferative disorders in three patients]. Hernández Sánchez MC; García Quiroga H; Ulibarrena Redondo C; Méndez Sánchez JA An Med Interna; 2008 Feb; 25(2):78-80. PubMed ID: 18432364 [TBL] [Abstract][Full Text] [Related]
11. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: occupational and familial aspects. Giles GG; Lickiss JN; Baikie MJ; Lowenthal RM; Panton J J Natl Cancer Inst; 1984 Jun; 72(6):1233-40. PubMed ID: 6587145 [TBL] [Abstract][Full Text] [Related]
12. [Cytogenetic study of exudates secondary to hematologic processes]. Bello MJ; Rey JA; Moreno S; Martínez Castro P; Benítez J Sangre (Barc); 1988 Jun; 33(3):165-70. PubMed ID: 3175812 [No Abstract] [Full Text] [Related]
13. Marker chromosome 14q + in human cancer and leukemia. Mitelman F Adv Cancer Res; 1981; 34():141-70. PubMed ID: 7025591 [No Abstract] [Full Text] [Related]
14. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: patterns in space and time. Lickiss JN; Giles GG; Baikie MJ; Lowenthal RM; Challis D; Panton J J Natl Cancer Inst; 1984 Jun; 72(6):1223-31. PubMed ID: 6587144 [TBL] [Abstract][Full Text] [Related]
15. [Principles and results of 5 years' work on a register of hemoblastoses]. Lapin BA; Lebedeva IuL; Lebedev VN; Iakovleva LA; Finchenko GA Vopr Onkol; 1980; 26(1):18-23. PubMed ID: 6444476 [TBL] [Abstract][Full Text] [Related]